Clinical trials
Completed Respiratory Syncytial Virus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
110 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 1 |
| 2010 | 2 |
| 2011 | 5 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 7 |
| 2015 | 7 |
| 2016 | 5 |
| 2017 | 5 |
| 2018 | 8 |
| 2019 | 7 |
| 2020 | 7 |
| 2021 | 7 |
| 2022 | 8 |
| 2023 | 11 |
| 2024 | 8 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 110 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 21 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 20 |
| Enanta Pharmaceuticals, Inc | 10 |
| MedImmune LLC | 7 |
| Sanofi Pasteur, a Sanofi Company | 5 |
| Gilead Sciences | 4 |
| Novavax | 4 |
| Alnylam Pharmaceuticals | 3 |
| AstraZeneca | 3 |
| MicroDose Therapeutx, Inc | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Syncytial Virus Infections | 110 |
| Respiratory Tract Infections | 5 |
| Influenza, Human | 4 |
| COVID-19 | 3 |
| Bronchiolitis | 2 |
| Coronavirus Infections | 2 |
| Adenoviridae Infections | 1 |
| Asthma | 1 |
| Coxsackievirus Infections | 1 |
| Infections | 1 |
Trials
Showing 1 to 25 of 110. Each trial links to its page on Pharma Observatory.
10 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.